If you ever find a personal or work task daunting, you might just need to rethink how you approach it. Pomodoro apps and ...

Create a no-code AI researcher with two research modes and verifiable links, so you get quick answers and deeper findings ...

Want to turn a single image into a full cinematic ad? In this video, I’ll walk you through how to create high-quality, ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

IONOS has a 99.99% uptime guarantee for its hosted web pages. If the company doesn't hit the target, you can claim an account ...

Especially on X, algorithmic culture is characterized by ceaseless iteration: Everything that’s happening is piled atop all ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most active US stocks to buy according to analysts. On December 8, ...

Earlier in December 2025, Recursion Pharmaceuticals reported positive Phase 1b/2 TUPELO trial data for REC-4881 in familial adenomatous polyposis, showing rapid and durable reductions in polyp burden ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...